Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus
mBio · 08.05.2024 · 15 (5)
DOI: 10.1128/mbio.02889-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift mBio, erschienen am 08.05.2024. Verfasst von Li-Yin Lai und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, beta-Lactam Resistance, beta-Lactams, Methicillin-Resistant Staphylococcus aureus. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Infections caused by Staphylococcus aureus are a leading cause of mortality worldwide. S. aureus infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are particularly difficult to treat due to their resistance to next-generation β-lactams (NGBs) such as methicillin, nafcillin, and oxacillin. Resistance to NGBs, which is alternatively known as broad-spectrum β-lactam resistance, is classically mediated by PBP2a, a penicillin-binding protein encoded by mecA (or mecC ) in MRSA. Thus, presence of mec genes among S. aureus spp. serves as the predictor of resistance to NGBs and facilitates determination of the proper therapeutic strategy for a staphylococcal infection. Although far less appreciated, mecA -deficient S. aureus strains can also exhibit NGB resistance. These strains, which are collectively termed as methicillin-resistant lacking mec (MRLM), are currently being identified in increasing numbers among natural resistant isolates of S. aureus . The mechanism/s through which MRLMs produce resistance to NGBs remains unknown. In this study, we demonstrate that mutations that alter PBP4 and GdpP functions, which are often present among MRLMs, can synergistically mediate resistance to NGBs. Furthermore, our results unravel that this novel mechanism potentially enables MRLMs to produce resistance toward NGBs at levels comparable to those of MRSAs. Our study provides a fresh new perspective about alternative mechanisms of NGB resistance, challenging our current overall understanding of high-level, broad-spectrum β-lactam resistance in S. aureus . It thus suggests reconsideration of the current approach toward diagnosis and treatment of β-lactam-resistant S. aureus infections. IMPORTANCE In Staphylococcus aureus , high-level, broad-spectrum resistance to β-lactams such as methicillin, also referred to as methicillin resistance, is largely attributed to mecA . This study demonstrates that S. aureus strains that lack mecA but contain mutations that functionally alter PBP4 and GdpP can also mediate high-level, broad-spectrum resistance to β-lactams. Resistance brought about by the synergistic action of functionally altered PBP4 and GdpP was phenotypically comparable to that displayed by mecA , as seen by increased bacterial survival in the presence of β-lactams. An analysis of mutations detected in naturally isolated strains of S. aureus revealed that a significant proportion of them had similar pbp4 and G GDEF d omain p rotein containing p hosphodiesterase ( gdpP ) mutations, making this study clinically significant. This study not only identifies important players of non-classical mechanisms of β-lactam resistance but also indicates reconsideration of current clinical diagnosis and treatment protocols of S. aureus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbial Pathogenesis, School of Dentistry, University of Maryland Baltimore, Baltimore, Maryland, USA.
- Institute of Marine and Environmental Technology (IMET), Baltimore, Maryland, USA.
- Instituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
- Department of Clinical Pharmacy, Drug Research Unit, University of California, San Francisco, California, USA.
- UCIBIO-REQUIMTE, Departamento de Ciências da Vida, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal.
- Division of Infectious Diseases, School of Medicine, University of California San Francisco, San Francisco, California, USA.
ORCID-Profile: Nidhi Satishkumar, Liusheng Huang, Mariana G Pinho, Som S Chatterjee
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lai, L. Y., Satishkumar, N., Cardozo, S., Hemmadi, V., Marques, L. B., Huang, L., Filipe, S. R., Pinho, M. G., Chambers, H. F., & Chatterjee, S. S. (2024). Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus. mBio, 15(5). https://doi.org/10.1128/mbio.02889-23
Vancouver
Lai LY, Satishkumar N, Cardozo S, Hemmadi V, Marques LB, Huang L, et al. Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus. mBio. 2024;15(5). doi:10.1128/mbio.02889-23
BibTeX
@article{Lai2024,
author = {Lai, Li-Yin and Satishkumar, Nidhi and Cardozo, Sasha and Hemmadi, Vijay and Marques, Leonor B and Huang, Liusheng and Filipe, Sergio R and Pinho, Mariana G and Chambers, Henry F and Chatterjee, Som S},
title = {Altered PBP4 and GdpP functions synergistically mediate MRSA-like high-level, broad-spectrum β-lactam resistance in Staphylococcus aureus},
journal = {mBio},
year = {2024},
volume = {15},
number = {5},
doi = {10.1128/mbio.02889-23}
}
EUVIMED